Ligand Pharmaceuticals Inc (LGND) – Strategy, SWOT and Corporate Finance Report

Ligand Pharmaceuticals Inc (LGND) – Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate actions, providing a 360˚ view of the company

Key Highlights

Ligand Pharmaceuticals Inc (Ligand) develops and acquires technologies that help biopharmaceutical companies in the discovery and development of medicines. Its major research technologies include formulation science, structure-based drug design, antibody discovery technologies and liver targeted pro-drug technologies, which assist pharmaceutical companies in securing prescription drug approvals. Its technologies and research capabilities contributed the development of a diversified portfolio of biotechnology and pharmaceutical products for inflammatory, respiratory central nervous system, oncology, ophthalmology, haematology, musculoskeletal disorder, osteoporosis, and among others. Ligand also offers late-stage development, regulatory management and commercialization support in partnership with other pharmaceutical companies. Ligand is headquartered in San Diego, California, the US.

Scope

• Detailed information on Ligand Pharmaceuticals Inc required for business and competitor intelligence needs

• A study of the major internal and external factors affecting Ligand Pharmaceuticals Inc in the form of a SWOT analysis

• An in-depth view of the business model of Ligand Pharmaceuticals Inc including a breakdown and examination of key business segments

• News about Ligand Pharmaceuticals Inc, such as business expansion, restructuring, and contract wins

• Large number of easy-to-grasp charts and graphs that present important data and key trends

Reasons to buy

• Gain understanding of Ligand Pharmaceuticals Inc and the factors that influence its strategies.

• Track strategic initiatives of the company and latest corporate news and actions.

• Assess Ligand Pharmaceuticals Inc as a prospective partner, vendor or supplier.

• Support sales activities by understanding your customers' businesses better.

• Stay up to date on Ligand Pharmaceuticals Incs business structure, strategy and prospects.

Note: Some sections may be missing if data is unavailable for the company.

Companies mentioned

Trianni Inc

TransGenic Inc

Regeneron Pharmaceuticals Inc

Gilead Sciences Inc

Atara Biotherapeutics Inc

Ablexis LLC

AbCellera Biologics Inc

Table of Contents

Table of Contents

List of Tables

List of Figures

Section 1 - About the Company

Ligand Pharmaceuticals Inc - Key Facts

Ligand Pharmaceuticals Inc - Key Employees

Ligand Pharmaceuticals Inc - Key Employee Biographies

Ligand Pharmaceuticals Inc - Major Products and Services

Ligand Pharmaceuticals Inc - History

Ligand Pharmaceuticals Inc - Company Statement

Ligand Pharmaceuticals Inc - Locations And Subsidiaries

Head Office

Other Locations & Subsidiaries

Section 2 – Company Analysis

Company Overview

Ligand Pharmaceuticals Inc - Business Description

Business Segment: Captisol Sales

Performance

Business Segment: Contract Revenue

Performance

Business Segment: Royalties

Performance

R&D Overview

Ligand Pharmaceuticals Inc - Corporate Strategy

Ligand Pharmaceuticals Inc - SWOT Analysis

SWOT Analysis - Overview

Ligand Pharmaceuticals Inc - Strengths

Ligand Pharmaceuticals Inc - Weaknesses

Ligand Pharmaceuticals Inc - Opportunities

Ligand Pharmaceuticals Inc - Threats

Ligand Pharmaceuticals Inc - Key Competitors

Section 3 – Company Financial Ratios

Financial Ratios - Capital Market Ratios

Financial Ratios - Annual Ratios

Performance Chart

Financial Performance

Financial Ratios - Interim Ratios

Financial Ratios - Ratio Charts

Section 4 – Company’s Lifesciences Financial Deals and Alliances

Ligand Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021

Ligand Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021

Ligand Pharmaceuticals Inc, Recent Deals Summary

Section 5 – Company’s Recent Developments

May 03, 2021: Ligand Reports First Quarter 2021 Financial Results

Feb 03, 2021: Ligand Reports Fourth Quarter and Full Year 2020 Financial Results

Jan 20, 2021: Ligand’s Q4 financial results to reported February 2021

Oct 30, 2020: Ligand reports third quarter 2020 financial results

Aug 11, 2020: Ligand Pharmaceuticals agrees to acquire Pfenex for $516m

Aug 03, 2020: Ligand reports second quarter 2020 financial results

May 06, 2020: Ligand reports first quarter 2020 financial results

Apr 06, 2020: Ligand provides a corporate update and announces May 6th as the date for first quarter earnings call

Mar 10, 2020: Ligand’s presentation at the Barclays Global Healthcare Conference now a webcast only, new slides available on Ligand.com

Feb 27, 2020: Ligand raises 2020 financial guidance due to higher captisol material sales

Section 6 – Appendix

Methodology

Ratio Definitions

About MarketLine

Contact Us

Disclaimer

List of Tables

List of Tables

Ligand Pharmaceuticals Inc, Key Facts

Ligand Pharmaceuticals Inc, Key Employees

Ligand Pharmaceuticals Inc, Key Employee Biographies

Ligand Pharmaceuticals Inc, Major Products and Services

Ligand Pharmaceuticals Inc, History

Ligand Pharmaceuticals Inc, Other Locations

Ligand Pharmaceuticals Inc, Subsidiaries

Ligand Pharmaceuticals Inc, Key Competitors

Ligand Pharmaceuticals Inc, Ratios based on current share price

Ligand Pharmaceuticals Inc, Annual Ratios

Ligand Pharmaceuticals Inc, Annual Ratios (Cont…1)

Ligand Pharmaceuticals Inc, Annual Ratios (Cont…2)

Ligand Pharmaceuticals Inc, Interim Ratios

Ligand Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021

Ligand Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Type, 2015 to YTD 2021

Ligand Pharmaceuticals Inc, Recent Deals Summary

Currency Codes

Capital Market Ratios

Equity Ratios

Profitability Ratios

Cost Ratios

Liquidity Ratios

Leverage Ratios

Efficiency Ratios

List of Figures

List of Figures

Ligand Pharmaceuticals Inc, Performance Chart (2016 – 2020)

Ligand Pharmaceuticals Inc, Ratio Charts

Ligand Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals By Year, 2015 to YTD 2021

Ligand Pharmaceuticals Inc, Pharmaceuticals & Healthcare, Deals by Type, 2015 to YTD 2021

    Pricing

Discounts available for multiple purchases.

reportstore@marketline.com
+44 20 7947 2745

Saved reports